The high prevalence of cannabis use and the potential for negative effects indicate the need for effective prevention strategies and treatment of people who use cannabis. Studies show that harm reduction (HR) in cannabis use is effective in minimising the harmful consequences of the substance. However, health professionals often misunderstand it and resist its adoption due to various obstacles. To our knowledge, there has been no review of the scientific literature on the factors that facilitate or hinder practitioners’ adoption of HR in cannabis use. To fill this gap, we aim to identify, through a scoping review, facilitators and barriers to healthcare providers’ adoption of HR in cannabis use in Organisation for Economic Cooperation and Development (OECD) countries.
Our methodology will be guided by the six-step model initially proposed by Arksey and O’Malley (2005). The search strategy will be executed on different databases (Medline, PsycINFO, CINAHL, Web of Science, Embase, Sociological Abstracts, Érudit, BASE, Google Web and Google Scholar) and will cover articles published between 1990 and October 2022. Empirical studies published in French or English in an OECD country and identifying factors that facilitate or hinder healthcare providers’ adoption of HR in cannabis use, will be included. Reference lists of the selected articles as well as relevant systematic reviews will be scanned to identify any missed publications by the electronic searches.
Ethics approval is not required. The results will be disseminated through various activities (eg, publication in peer-reviewed journals, conferences, webinars and knowledge translation activities). The results will also allow us to conduct a future study aiming to develop and implement a knowledge translation process among healthcare practitioners working with youth in Quebec in order to enhance their adoption of HR in cannabis use.
Oral pre-exposure prophylaxis (PrEP) is a highly effective HIV prevention method; however, uptake and persistence have been low among southern African women. A dual prevention pill (DPP) that combines PrEP with oral contraception (OC) may increase PrEP use and better meet women’s sexual and reproductive health needs. We will gauge the DPP’s acceptability in two cross-over clinical trials.
PC952 (Zimbabwe) and PC953 (South Africa) will compare acceptability, adherence and preference for an over-encapsulated DPP versus PrEP and OCs taken separately. HIV-negative, non-pregnant cisgender females in Johannesburg, South Africa (n=96, 16–40 years) and Harare, Zimbabwe (n=30, 16–24 years) will be randomised 1:1 to the order of regimens—DPP or two separate tablets—each used for three 28-day cycles, followed by a 6-month choice period in South Africa. Monthly clinic visits include HIV and pregnancy testing; safety assessments and risk reduction and adherence counselling. We will assess adherence (monthly) based on tenofovir diphosphate drug levels in dried blood spots and by self-report. We will evaluate acceptability (monthly) and preference (end of cross-over) via computer-assisted self-interviewing and in-depth interviews with a subset of participants. Data collection started in September 2022 and ended in January 2024.
PC952 was approved by the Ministry of Health and Child Care, Medical Research Council, Research Council and Medicines Control Authority of Zimbabwe; the Chitungwiza City Health Ethics Committee; and the Joint Research Ethics Committee for the University of Zimbabwe Faculty of Medicine and Health Sciences and Parirenyatwa Group of Hospitals. PC953 was approved by the South African Health Products Regulatory Authority and the University of the Witwatersrand’s Human Research Ethics Committee. The Population Council IRB approved both studies. We will disseminate results in open-access journals, clinical trials registries, and at local and international meetings and conferences.
To prospectively examine the association between the duration of unemployment among job seekers and changes in alcohol use in a year.
A prospective study.
French population-based CONSTANCES cohort.
We selected 84 943 participants from the CONSTANCES cohort included between 2012 and 2019 who, at baseline and 1-year follow-up, were either employed or job-seeking.
Multinomial logistic regression models computed the odds of reporting continuous no alcohol use, at-risk alcohol use, increased or decreased alcohol use compared with being continuously at low risk and according to employment status. The duration of unemployment was self-reported at baseline; thus, the employment status at 1-year follow-up was categorised as follows: (1) employed, (2) return to employment since less than a year, (3) unemployed for less than 1 year, (4) unemployed for 1 to 3 years and (5) unemployed for 3 years or more. Analyses were adjusted for age, gender, education, household monthly income, marital status, self-rated health, smoking status and depressive state.
Compared with being continuously at low risk (ie, ≤10 drinks per week), the unemployment categories were associated in a dose-dependent manner with an increased likelihood of reporting continuous no alcohol use (OR: 1.74–2.50), being continuously at-risk (OR: 1.21–1.83), experiencing an increase in alcohol use (OR: 1.21–1.51) and a decrease in alcohol use (OR: 1.17–1.84).
Although our results suggested an association between the duration of unemployment and a decrease in alcohol use, they also revealed associations between at-risk and increased alcohol use. Thus, screening for alcohol use among unemployed job seekers must be reinforced, especially among those with long-term unemployment.
Objetivo: recopilar evidencia científica sobre la implementación y evaluación del uso de instrumentos para la identificación temprana del deterioro clínico en pacientes no infectados por SARS-COV-2 en unidades de hospitalización de adultos. Método: revisión integradora realizada en las bases de datos Latin American and Caribbean Literature on Health Sciences, Medical Literature Analysis and Retrieval System Online, Web Of Science y SCOPUS, utilizando la siguiente estrategia de búsqueda: (“Early Medical Intervention” OR “Early Warning Systems” O “Puntuación de alerta temprana”) Y (“Deterioro clínico”). Resultados: se seleccionaron ocho artículos que abordaron la implementación de herramientas para la identificación temprana de deterioro clínico en unidades de hospitalización y evaluaron sus resultados a través de indicadores de incidencia de paro cardiorrespiratorio, incidencia de ingreso no planificado en UTI, incidencia de cirugía de emergencia, mortalidad e incidencia de enfermedad renal. lesión. Conclusión: la implementación de herramientas que permiten la identificación temprana del deterioro clínico en las unidades de hospitalización tuvo un impacto positivo en los indicadores institucionales.
Objetivo: Identificar os efeitos da pandemia da COVID 19 nos profissionais atuantes no atendimento pré-hospitalar. Método: revisão integrativa, conduzida de acordo com o protocolo prisma, por meio das bases de dados: Medline/PubMed, Lilacs, SciElo, BDENF, CUIDEN, CINAHAL. Adotaram-se os Descritores em Ciências da Saúde (DeCS): “Saúde do trabalhador” “Pandemia” “COVID 19” “Atendimento pré-hospitalar” “Segurança” “Profissionais de saúde” “Trabalho”. Após a aplicação dos critérios de inclusão, foram selecionados treze artigos que compuseram a amostra do estudo. Resultados: dezoito artigos foram analisados e duas categorias foram construídas: risco de contaminação e exposição ocupacional dos profissionais da saúde que cuidam de pacientes acometidos pela COVID-19 e risco de adoecimento psicoemocional dos profissionais da saúde que cuidam pacientes acometidos pela COVID-19. Conclusão: A revisão mostrou os potenciais efeitos sobre a saúde dos profissionais durante o atendimento de pacientes acometidos pela COVID-19. E a importância da implementação de estratégias de intervenção focadas nos riscos ocupacionais.